[go: up one dir, main page]

PE20090803A1 - Compuestos triazolil aminopirimidin como inhibidores de plk1 - Google Patents

Compuestos triazolil aminopirimidin como inhibidores de plk1

Info

Publication number
PE20090803A1
PE20090803A1 PE2008000797A PE2008000797A PE20090803A1 PE 20090803 A1 PE20090803 A1 PE 20090803A1 PE 2008000797 A PE2008000797 A PE 2008000797A PE 2008000797 A PE2008000797 A PE 2008000797A PE 20090803 A1 PE20090803 A1 PE 20090803A1
Authority
PE
Peru
Prior art keywords
compounds
triazolil
methyl
aminopyrimidin
thiofen
Prior art date
Application number
PE2008000797A
Other languages
English (en)
Inventor
Harold Burns Brooks
Delu Jiang
Millen William Thomas Mc
Jason Scott Sawyer
Melissa Kate Slater
Yan Wang
James Robert Henry
Hong Hu
Sachin Govindlal Maniar
Hong-Yu Li
Joyce Z Crich
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20090803A1 publication Critical patent/PE20090803A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

REFERIDA A UN COMPUESTO DERIVADO DE TRIAZOLIL AMINOPIRIMIDINA DE FORMULA (I), DONDE R1 ES H, METILO, CICLOPROPILO, ENTRE OTROS; R2 ES HIDROGENO; R3 ES H, METILO, F, ENTRE OTROS; R4 ES H, METILO, FLUORO O CLORO; R5 ES H O HIDROXIMETILO; R6 ES H O METILO. SON COMPUESTOS PREFERIDOS: N-(2-(1H-1,2,3-TRIAZOL-1-IL)ETIL)-4-(7-(2-FLUORO-5-METILPIRIDIN-4-IL)BENZO[b]TIOFEN-2-IL)PIRIMIDIN-2-AMINA, N-(2-(1H-1,2,3-TRIAZOL-1-IL)ETIL)-4-(7-(5-CICLOPROPIL-2-FLUOROPIRIDIN-4-IL)BENZO[b]TIOFEN-2-IL)-5-FLUOROPIRIMIDIN-2-AMINA, N-(2-(1H-1,2,3-TRIAZOL-1-IL)ETIL)-4-(7-(5-((DIMETILAMINO)-2-FLUOROPIRIDIN-4-IL)-BENZO[b]TIOFEN-2-IL)-5-FLUOROPIRIMIDIN-2-AMINA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD INIHIBITORIA SOBRE Plk1 Y SON UTILES EN EL TRATAMIENTO DEL CANCER
PE2008000797A 2007-05-16 2008-05-07 Compuestos triazolil aminopirimidin como inhibidores de plk1 PE20090803A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93833307P 2007-05-16 2007-05-16

Publications (1)

Publication Number Publication Date
PE20090803A1 true PE20090803A1 (es) 2009-07-11

Family

ID=39967594

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000797A PE20090803A1 (es) 2007-05-16 2008-05-07 Compuestos triazolil aminopirimidin como inhibidores de plk1

Country Status (15)

Country Link
US (1) US8114872B2 (es)
EP (1) EP2155735A2 (es)
JP (1) JP5204838B2 (es)
KR (1) KR101131254B1 (es)
CN (1) CN101679396B (es)
AR (1) AR066472A1 (es)
AU (1) AU2008254318B2 (es)
BR (1) BRPI0811611A2 (es)
CA (1) CA2687474A1 (es)
CL (1) CL2008001322A1 (es)
EA (1) EA015574B1 (es)
MX (1) MX2009012233A (es)
PE (1) PE20090803A1 (es)
TW (1) TW200902012A (es)
WO (1) WO2008144222A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2125794E (pt) 2006-12-21 2011-01-10 Lilly Co Eli Compostos imidazolidinonilo aminopirimidina para o tratamento do cancro
CN101563342B (zh) 2006-12-21 2012-09-05 伊莱利利公司 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
EP2155734A2 (en) * 2007-05-16 2010-02-24 Eli Lilly And Company Triazolyl aminopyrimidine compounds
US8114872B2 (en) 2007-05-16 2012-02-14 Eli Lilly And Company Triazolyl aminopyrimidine compounds
WO2014172190A1 (en) 2013-04-15 2014-10-23 E. I. Du Pont De Nemours And Company Fungicidal amides

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) * 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7521457B2 (en) * 2004-08-20 2009-04-21 Boehringer Ingelheim International Gmbh Pyrimidines as PLK inhibitors
WO2006021548A1 (de) * 2004-08-27 2006-03-02 Boehringer Ingelheim International Gmbh Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
JP4932735B2 (ja) * 2004-12-17 2012-05-16 アムジエン・インコーポレーテツド アミノピリミジン化合物および使用方法
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
EP2001480A4 (en) 2006-03-31 2011-06-15 Abbott Lab Indazole CONNECTIONS
CN101563342B (zh) 2006-12-21 2012-09-05 伊莱利利公司 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物
EP2155734A2 (en) * 2007-05-16 2010-02-24 Eli Lilly And Company Triazolyl aminopyrimidine compounds
US8114872B2 (en) 2007-05-16 2012-02-14 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Also Published As

Publication number Publication date
EP2155735A2 (en) 2010-02-24
KR101131254B1 (ko) 2012-04-24
CA2687474A1 (en) 2008-11-27
WO2008144222A2 (en) 2008-11-27
KR20090130246A (ko) 2009-12-21
BRPI0811611A2 (pt) 2014-11-04
CN101679396B (zh) 2012-06-06
AU2008254318A1 (en) 2008-11-27
WO2008144222A3 (en) 2009-01-15
MX2009012233A (es) 2009-12-01
JP2010527364A (ja) 2010-08-12
US8114872B2 (en) 2012-02-14
EA015574B1 (ru) 2011-10-31
CL2008001322A1 (es) 2009-05-22
CN101679396A (zh) 2010-03-24
AR066472A1 (es) 2009-08-19
EA200971067A1 (ru) 2010-04-30
AU2008254318B2 (en) 2012-04-05
US20100130466A1 (en) 2010-05-27
JP5204838B2 (ja) 2013-06-05
TW200902012A (en) 2009-01-16

Similar Documents

Publication Publication Date Title
PE20090160A1 (es) COMPUESTOS AMINO-5-[4-(DIFLUOROMETOXI)FENIL SUSTITUIDO]-5-FENILIMIDAZOLONA COMO INHIBIDORES DE ß-SECRETASA
PE20091734A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20090895A1 (es) Derivados de triazol como inhibidores de la jak quinasa
PE20201185A1 (es) Inhibidores de la oxacina monoacilglicerol lipasa (magl)
PE20090772A1 (es) Derivados de bencimidazol
PE20080927A1 (es) Derivados de benzoil-amino-heterociclilo como activadores de la glucoquinasa (glk)
PE20120058A1 (es) Derivados de imidazopirazina como inhibidores de syk
PE20120107A1 (es) Inhibidores de proteina cinasa
PE20140918A1 (es) Compuestos de benzoxepina inhibidores de la pi3k
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
PE20070720A1 (es) Derivados de fenilo como antagonistas del receptor 3 de la histamina
PE20100138A1 (es) Derivados de morfolino pirimidina usados en enfermedades relacionadas en mtor quinasa y/o pi3k
PE20090773A1 (es) Derivados de morfolina pirimidina
PE20120693A1 (es) Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
ECSP088863A (es) Compuestos que son agonistas de receptores muscarínicos y que pueden ser eficaces en el tratamiento del dolor, la enfermedad de alzheimer y/o la esquizofrenia
PE20141855A1 (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
PE20090996A1 (es) Derivados de pirrolopirimidina como inhibidores de cinasa jak3
PE20141974A1 (es) Compuestos de heterociclilo
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
PE20080948A1 (es) Derivados de imidazol como moduladores de la senda de hedgehog
PE20110433A1 (es) Antagonistas de la via hedgehog de ftalazina disustituida
ATE418548T1 (de) Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
PE20120357A1 (es) Derivados de benzofurano

Legal Events

Date Code Title Description
FD Application declared void or lapsed